InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
4
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Kariv Tomer. Officer active across 3 companies, notably Eloxx Pharmaceuticals, Inc.. Aggregated, 6 reports have been recorded. Split: 4 buys · 0 sell. Total volume traded: €1.4m. History available since 13 May 2021. The latest transaction was disclosed on 4 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kariv Tomer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
5,250 股0Common StockSEC:0001415889-25-015977:0
3,539 股100.0% 占其流量Common StockSEC:0001209191-22-059051:0
1,280,624 股@ US$1.35100.0% 占其流量Common StockSEC:0001104659-21-067333:0
标准退出：2021年8月11日 (T+90)
707,868 股Common StockSEC:0000914190-16-000516:0
标准退出：2016年4月11日 (T+90)
533,208 股Common StockSEC:0000914190-16-000516:1
标准退出：2016年4月11日 (T+90)
206,986 股Common StockSEC:0000914190-16-000516:2
标准退出：2016年4月11日 (T+90)
6 条申报中的 6 条
About Kariv Tomer
Kariv Tomer is a declarant and a director at Arno Therapeutics, Inc, Eloxx Pharmaceuticals, Inc. and Keros Therapeutics, Inc. He has 6 filings in total, and across the sampled recent filings the acquisitions total 2862963 EUR, with no sales, between 2016-01-14 and 2022-11-30.
